Inhibition of insulin binding by concanavalin-A

Area of Science:

• Cell biology
• Biochemistry
• Endocrinology

Background:

• Insulin binding to its receptor is crucial for glucose homeostasis.
• Cell surface interactions can modulate receptor function.
• Concanavalin-A (Con-A) is a lectin known to bind cell surface glycoproteins.

Purpose of the Study:

• To investigate the effect of Concanavalin-A (Con-A) on insulin binding to IM-9 lymphoblastoid cells.
• To elucidate the mechanism behind Con-A-induced alterations in insulin binding.

Main Methods:

• Incubation of IM-9 cells with varying concentrations of Con-A.
• Scatchard plot analysis to determine receptor number.
• Experiments using alpha-methyl mannoside to assess reversibility and mechanism.
• Testing the effects of bivalent succinyl Con-A and inhibitors of cytoskeleton and protein synthesis.

Main Results:

• Prolonged Con-A exposure reduced insulin binding, suggesting a decrease in insulin receptor number.
• The Con-A effect mimicked insulin down-regulation in terms of kinetics.
• Alpha-methyl mannoside inhibited and reversed Con-A's effect, indicating steric hindrance.
• Bivalent Con-A was less effective than tetravalent Con-A, further supporting steric hindrance.

Conclusions:

• Concanavalin-A reduces insulin binding to IM-9 cells primarily through steric hindrance, not by affecting protein synthesis or cytoskeleton.
• The Con-A-induced reduction in insulin binding resembles insulin receptor down-regulation.
• Understanding lectin-receptor interactions provides insights into cell surface modulation of hormone signaling.